Dolutegravir intermediate-1
Product Specifications
UNSPSC Description
Dolutegravir intermediate-1 is a synthetic intermediate of Dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
Target Antigen
HIV
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/Dolutegravir_intermediate-1.html
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(OC)C(C(C(O)=O)=CN1CC(OC)OC)=O)OC
Molecular Weight
315.28
References & Citations
[1]Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100083/Dolutegravir-intermediate-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100083/Dolutegravir-intermediate-1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1335210-23-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-08861APC 100 µL
Mouse Monoclonal DREF Antibody (PCRP-ZBED1-1E1) [Allophycocyanin]
Ask
View Details